Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population.

Chen YB, Mu CY, Chen C, Huang JA.

Asia Pac J Clin Oncol. 2014 Jun;10(2):e1-6. doi: 10.1111/ajco.12037. Epub 2012 Nov 21.

PMID:
23167931
2.

PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer.

Cheng S, Zheng J, Zhu J, Xie C, Zhang X, Han X, Song B, Ma Y, Liu J.

Int J Biol Markers. 2015 Nov 11;30(4):e364-8. doi: 10.5301/jbm.5000170.

PMID:
26349666
3.

FoxP3 genetic variants and risk of non-small cell lung cancer in the Chinese Han population.

He YQ, Bo Q, Yong W, Qiu ZX, Li YL, Li WM.

Gene. 2013 Dec 1;531(2):422-5. doi: 10.1016/j.gene.2013.08.066. Epub 2013 Sep 10.

PMID:
24035934
4.

[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].

Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH.

Ai Zheng. 2005 Mar;24(3):305-10. Chinese.

PMID:
15757531
5.

Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer.

Yu X, Rao J, Lin J, Zhang Z, Cao L, Zhang X.

Mol Cancer. 2014 Mar 12;13:56. doi: 10.1186/1476-4598-13-56.

6.

[A study on the relationship between endoplasmic reticulum aminopeptidase2 genetic polymorphisms and non-small cell lung cancer in Yunnan Han population].

Zhou J, Ma Q, Guo C, Shi L, Yao Y, Yu J, Zhang X.

Zhonghua Jie He He Hu Xi Za Zhi. 2014 Dec;37(12):909-14. Chinese.

PMID:
25609128
7.

Association of miR-502-binding site single nucleotide polymorphism in the 3'-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population.

Yang S, Guo H, Wei B, Zhu S, Cai Y, Jiang P, Tang J.

Acta Biochim Biophys Sin (Shanghai). 2014 Feb;46(2):149-54. doi: 10.1093/abbs/gmt138. Epub 2013 Dec 26.

PMID:
24374662
8.

The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients.

Li Y, Geng J, Wang Y, Lu Q, Du Y, Wang W, Li Z.

J Cancer Res Clin Oncol. 2012 Feb;138(2):311-6. doi: 10.1007/s00432-011-1098-6. Epub 2011 Nov 30.

PMID:
22127368
9.

Association of an A/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with Graves' disease in Japanese patients.

Hayashi M, Kouki T, Takasu N, Sunagawa S, Komiya I.

Eur J Endocrinol. 2008 Jun;158(6):817-22. doi: 10.1530/EJE-07-0649. Epub 2008 Mar 5.

10.

The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.

Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, Lin LY.

Lung Cancer. 2005 Dec;50(3):291-7. Epub 2005 Aug 24.

PMID:
16122836
11.

Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: A case control study.

Rafrafi A, Chahed B, Kaabachi S, Kaabachi W, Maalmi H, Hamzaoui K, Sassi FH.

Hum Immunol. 2013 Oct;74(10):1368-74. doi: 10.1016/j.humimm.2013.06.033. Epub 2013 Jul 2.

PMID:
23831257
12.

Interleukin-4 -590T/C polymorphism influences the susceptibility to nonsmall cell lung cancer.

Li X, Shi W, Yu G, Lin L, Yang B, Li J, Guo W, Tang C, Wang H, Gao H, Qin H, Liu Y, Liu X.

DNA Cell Biol. 2012 May;31(5):797-800. doi: 10.1089/dna.2011.1425. Epub 2011 Dec 5.

PMID:
22142023
13.

No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.

Wang Y, Fang S, Wei L, Wang R, Jin X, Wen D, Li Y, Guo W, Wang N, Zhang J.

Lung Cancer. 2005 Aug;49(2):155-61.

PMID:
15949868
14.

[A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].

Lou Y, Fang CQ, Li JH.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Feb;24(1):59-62. Chinese.

PMID:
17285546
15.

Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population.

Liu Y, Bi Y, Lin J, Cao L, He B, Zhang Z, Cui Y, Zhang X.

Tumour Biol. 2015 Mar;36(3):1955-62. doi: 10.1007/s13277-014-2801-4. Epub 2014 Nov 15.

PMID:
25394898
16.

Effect of hENT1 polymorphism G-706C on clinical outcomes of gemcitabine-containing chemotherapy for Chinese non-small-cell lung cancer patients.

Wu F, Zhang J, Hu N, Wang H, Xu T, Liu Y, Zheng Y.

Cancer Epidemiol. 2014 Dec;38(6):728-32. doi: 10.1016/j.canep.2014.08.008. Epub 2014 Sep 20.

PMID:
25246379
17.

Association between interleukin-4 polymorphisms and environment and nonsmall cell lung cancer in Chinese population.

Gu J, Shen Y, Zhang Y.

J Cancer Res Ther. 2014 Nov;10 Suppl:C135-9. doi: 10.4103/0973-1482.145839.

18.

Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.

Zhang K, Tang S, Cao S, Hu L, Pan Y, Ma H, Guo X, Wu S, Shen H, Hu Z.

Cancer Epidemiol. 2014 Aug;38(4):414-8. doi: 10.1016/j.canep.2014.03.013. Epub 2014 May 3.

PMID:
24797335
19.

SNCA rs3822086 C>T Polymorphism Increases the Susceptibility to Parkinson's Disease in a Chinese Han Population.

Jian CD, Huang JM, Meng LQ, Li XB, Huang RY, Shi SL, Wu Y, Qin C, Chen J, Zhang YM, Wang S, Feng YL, Zhou SN.

Genet Test Mol Biomarkers. 2015 Sep;19(9):481-7. doi: 10.1089/gtmb.2015.0046. Epub 2015 Jul 23.

PMID:
26203864
20.

The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.

Zhang J, Jin X, Fang S, Wang R, Li Y, Wang N, Guo W, Wang Y, Wen D, Wei L, Dong Z, Kuang G.

Carcinogenesis. 2005 Oct;26(10):1748-53. Epub 2005 Jun 1.

PMID:
15930031

Supplemental Content

Support Center